Literature DB >> 21316292

Cognitive outcome and reliable change indices two years following bilateral subthalamic nucleus deep brain stimulation.

Amy E Williams1, Gladys Marina Arzola, Adriana M Strutt, Richard Simpson, Joseph Jankovic, Michele K York.   

Abstract

Subthalamic nucleus deep brain stimulation (STN-DBS) is currently the treatment of choice for medication-resistant levodopa-related motor complications in patients with Parkinson's disease (PD). While STN-DBS often results in meaningful motor improvements, consensus regarding long-term neuropsychological outcome continues to be debated. We assessed the cognitive outcomes of 19 STN-DBS patients compared to a group of 18 medically-managed PD patients on a comprehensive neuropsychological battery at baseline and two years post-surgery. Patients did not demonstrate changes in global cognitive functioning on screening measures. However, neuropsychological results revealed impairments in nonverbal recall, oral information processing speed, and lexical and semantic fluency in STN-DBS patients compared to PD controls 2 years post-surgery in these preliminary analyses. Additionally, reliable change indices revealed that approximately 50% of STN-DBS patients demonstrated significant declines in nonverbal memory and oral information processing speed compared to 25-30% of PD controls, and 26% of STN-DBS patients declined on lexical fluency compared to 11% of PD patients. Approximately 30% of both groups declined on semantic fluency. The number of STN-DBS patients who converted to dementia 2 years following surgery was not significantly different from the PD participants (32% versus 16%, respectively). Our results suggest that neuropsychological evaluations may identify possible mild cognitive changes following surgery.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21316292      PMCID: PMC3109216          DOI: 10.1016/j.parkreldis.2011.01.011

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  27 in total

1.  Clinical significance: a statistical approach to defining meaningful change in psychotherapy research.

Authors:  N S Jacobson; P Truax
Journal:  J Consult Clin Psychol       Date:  1991-02

2.  Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up.

Authors:  W M M Schüpbach; N Chastan; M L Welter; J L Houeto; V Mesnage; A M Bonnet; V Czernecki; D Maltête; A Hartmann; L Mallet; B Pidoux; D Dormont; S Navarro; P Cornu; A Mallet; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-12       Impact factor: 10.154

3.  Chronic effects of dopaminergic replacement on cognitive function in Parkinson's disease: a two-year follow-up study of previously untreated patients.

Authors:  J Kulisevsky; C García-Sánchez; M L Berthier; M Barbanoj; B Pascual-Sedano; A Gironell; A Estévez-González
Journal:  Mov Disord       Date:  2000-07       Impact factor: 10.338

4.  Bilateral deep brain stimulation in Parkinson's disease: a multicentre study with 4 years follow-up.

Authors:  M C Rodriguez-Oroz; J A Obeso; A E Lang; J-L Houeto; P Pollak; S Rehncrona; J Kulisevsky; A Albanese; J Volkmann; M I Hariz; N P Quinn; J D Speelman; J Guridi; I Zamarbide; A Gironell; J Molet; B Pascual-Sedano; B Pidoux; A M Bonnet; Y Agid; J Xie; A-L Benabid; A M Lozano; J Saint-Cyr; L Romito; M F Contarino; M Scerrati; V Fraix; N Van Blercom
Journal:  Brain       Date:  2005-06-23       Impact factor: 13.501

5.  Enhanced or impaired cognitive function in Parkinson's disease as a function of dopaminergic medication and task demands.

Authors:  R Cools; R A Barker; B J Sahakian; T W Robbins
Journal:  Cereb Cortex       Date:  2001-12       Impact factor: 5.357

6.  Dopaminergic modulation of cortical function in patients with Parkinson's disease.

Authors:  Venkata S Mattay; Alessandro Tessitore; Joseph H Callicott; Alessandro Bertolino; Terry E Goldberg; Thomas N Chase; Thomas M Hyde; Daniel R Weinberger
Journal:  Ann Neurol       Date:  2002-02       Impact factor: 10.422

7.  Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial.

Authors:  Adrian Williams; Steven Gill; Thelekat Varma; Crispin Jenkinson; Niall Quinn; Rosalind Mitchell; Richard Scott; Natalie Ives; Caroline Rick; Jane Daniels; Smitaa Patel; Keith Wheatley
Journal:  Lancet Neurol       Date:  2010-04-29       Impact factor: 44.182

8.  Long term effects of bilateral subthalamic nucleus stimulation on cognitive function, mood, and behaviour in Parkinson's disease.

Authors:  A Funkiewiez; C Ardouin; E Caputo; P Krack; V Fraix; H Klinger; S Chabardes; K Foote; A-L Benabid; P Pollak
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-06       Impact factor: 10.154

9.  Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.

Authors:  Paul Krack; Alina Batir; Nadège Van Blercom; Stephan Chabardes; Valérie Fraix; Claire Ardouin; Adnan Koudsie; Patricia Dowsey Limousin; Abdelhamid Benazzouz; Jean François LeBas; Alim-Louis Benabid; Pierre Pollak
Journal:  N Engl J Med       Date:  2003-11-13       Impact factor: 91.245

10.  Impact of STN-DBS on life and health satisfaction in patients with Parkinson's disease.

Authors:  Joseph Ferrara; Alan Diamond; Christine Hunter; Anthony Davidson; Michael Almaguer; Joseph Jankovic
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-09-01       Impact factor: 10.154

View more
  27 in total

1.  Long-term cognitive outcome of bilateral subthalamic deep brain stimulation in Parkinson's disease.

Authors:  Han-Joon Kim; Beom S Jeon; Sun Ha Paek; Kyoung-Min Lee; Ji-Young Kim; Jee-Young Lee; Hee Jin Kim; Ji Young Yun; Young Eun Kim; Hui-Jun Yang; Gwanhee Ehm
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

2.  Nonmotor outcomes in Parkinson's disease: is deep brain stimulation better than dopamine replacement therapy?

Authors:  Rupam Borgohain; Rukmini Mridula Kandadai; Afshan Jabeen; Meena A Kannikannan
Journal:  Ther Adv Neurol Disord       Date:  2012-01       Impact factor: 6.570

Review 3.  The effect of STN DBS on modulating brain oscillations: consequences for motor and cognitive behavior.

Authors:  Fabian J David; Miranda J Munoz; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2020-06-03       Impact factor: 1.972

Review 4.  Influence of deep brain stimulation of the subthalamic nucleus on cognitive function in patients with Parkinson's disease.

Authors:  Bin Wu; Lu Han; Bo-Min Sun; Xiao-Wu Hu; Xiao-Ping Wang
Journal:  Neurosci Bull       Date:  2013-12-12       Impact factor: 5.203

5.  The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease.

Authors:  Lisa C Goelz; Fabian J David; John A Sweeney; David E Vaillancourt; Howard Poizner; Leonard Verhagen Metman; Daniel M Corcos
Journal:  Exp Brain Res       Date:  2016-11-14       Impact factor: 1.972

Review 6.  Psychiatric and Cognitive Effects of Deep Brain Stimulation for Parkinson's Disease.

Authors:  Adam Nassery; Christina A Palmese; Harini Sarva; Mark Groves; Joan Miravite; Brian Harris Kopell
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

7.  Improved sequence learning with subthalamic nucleus deep brain stimulation: evidence for treatment-specific network modulation.

Authors:  Hideo Mure; Chris C Tang; Miklos Argyelan; Maria-Felice Ghilardi; Michael G Kaplitt; Vijay Dhawan; David Eidelberg
Journal:  J Neurosci       Date:  2012-02-22       Impact factor: 6.167

8.  Cognitive outcome following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease-a comparative observational study in Indian patients.

Authors:  Kshiteeja Jain; Remya Ramesh; Syam Krishnan; Krishnakumar Kesavapisharady; K P Divya; Sankara P Sarma; Asha Kishore
Journal:  Acta Neurol Belg       Date:  2021-08-26       Impact factor: 2.396

Review 9.  Cognition and Depression Following Deep Brain Stimulation of the Subthalamic Nucleus and Globus Pallidus Pars Internus in Parkinson's Disease: A Meta-Analysis.

Authors:  Hannah L Combs; Bradley S Folley; David T R Berry; Suzanne C Segerstrom; Dong Y Han; Amelia J Anderson-Mooney; Brittany D Walls; Craig van Horne
Journal:  Neuropsychol Rev       Date:  2015-10-12       Impact factor: 7.444

10.  The serendipity case of the pedunculopontine nucleus low-frequency brain stimulation: chasing a gait response, finding sleep, and cognition improvement.

Authors:  Alessandro Stefani; Antonella Peppe; Salvatore Galati; Mario Stampanoni Bassi; Vincenza D'Angelo; Mariangela Pierantozzi
Journal:  Front Neurol       Date:  2013-06-05       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.